Cancer is the uncontrolled growth of cells that no longer respond to the body's control system. These cells learn to grow and spread outside where they first appeared.
The pancreas is a gland of the digestive system with two roles and is made up of two types of cells: one produces digestive juices and the other releases hormones that help regulate blood sugar levels. The abnormal growth of pancreatic cells can lead to pancreatic cancer. Most pancreatic cancers are formed in the cells that produce digestive enzymes. Pancreatic cancer often is uncovered when it is advanced but many treatments can improve how well people do.
Each year, over 3000 new cases of pancreatic cancer are diagnosed in Australia. The risk of being diagnosed with pancreatic cancer by age 85 is 1 in 55 for Australian men and 1 in 74 for Australian women. Pancreas cancer is the tenth most common cancer but the fifth most common cause of cancer death and is predicted to be the second most common by 2020. The five-year survival rate for pancreatic cancer is 8.7%
Pancreatic cancer can cause yellowing of the skin and whites of the eyes (jaundice), upper and middle abdominal pain, back pain, unexplained weight loss, appetite loss, fatigue, dark coloured urine and light-coloured stools.
Although the presence of these symptoms does not always mean you have pancreas cancer. These symptoms can also be caused by conditions that are not pancreatic cancer. But if you have these symptoms, please contact your general practitioner to initiate further investigations and referral to a pancreatic specialist.
You are at an increased risk of developing pancreatic cancer if you are a smoker, overweight, have diabetes, or have pancreatitis (inflammation of the pancreas) or a family history of pancreatic cancer. Although many people can develop pancreatic cancer have no risk factors, no family history and no genetic predisposing
Pancreatic cancer can be diagnosed by reviewing your medical history and performing a thorough physical examination. Professor Samra may order specific blood tests and other radiology tests such as CT scan, ultrasound, and possibly MRI, telescope examination of your internal organs such as endoscopic ultrasound, endoscopic retrograde cholangiopancreatography (ERCP). A biopsy to confirm the diagnosis may also be performed but is not always required.
To ascertain the stage of cancer and to individualise treatment a PET scan, Diagnostic Laparoscopy and Peritoneal Washings or MRI of the area may be required.
Yes, in the 1 in 5 who are diagnosed before cancer has spread, over 30% are alive at 5 years.
Cancer staging is the process of determining how much cancer is in the body and where it is located. Staging describes the severity of an individual's cancer based on the magnitude of the original (primary) tumour as well as on the extent cancer has spread in the body. Understanding the stage of cancer helps your treating specialists to develop a prognosis and design a treatment plan for individual patients.
Staging is based on the clinical or radiological extent of disease, the pathological extend of disease after a tumour is removed. Restaging is when the process is repeated after a round of treatment.
Clinical and radiological staging of pancreatic cancer is largely based on the appearance of the diagnostic tests undertaken. These may include a CT scan, MRI, Laparoscopy, endoscopic Ultrasound or PET scan. This is used to determine treatment.
The most common form of clinical staging is based on whether the pancreatic cancer is removable by surgery and whether it has grown into surrounding structures or spread to other organs. It is classified into 4 categories, but these are not the same as stage 1,2,3,4.
A simplified category of the pathological staging of pancreatic cancer is below
Treatment of pancreatic cancer depends upon how advanced it is and your general fitness. The goal of treatment is to remove or kill all the cancer cells in the body.
The standard treatments for pancreatic cancer involve surgery, radiation and chemotherapy. To undergo these treatments, it may be necessary to undergo an interventional procedure by a radiologist or gastroenterologist. These may include an ERCP, EUS or PTC to help the liver and pancreas work during treatment.
How these standard treatments are delivered is based on the clinical and radiological stage of the disease (see above). The order in which these treatments is applied is based on discussions at a specialist multidisciplinary meeting and is tailored (individualised) to each person and how to fit they are to undergo treatment. Patients also have the final say as to which treatments they will undertake, and this is always given the highest priority.
A simplified guide to treatment based on clinical staging
If the cancer is in advanced stages at the time it is diagnosed and has spread to other parts of the body, treatment involves both chemotherapy and occasionally radiation to control the activity of the disease. It is especially important to carefully managing symptoms for the best quality of life. It is best managed by a team of experienced doctors and nurses from many different specialities.
Prognosis depends on many variables, not least whether your tumour can be removed and whether you are fit enough to undergo radical therapy. There is also a wide variation in the survival of pancreatic cancer from person to person who has the same stage of the disease. The prognosis will also depend on how early the cancer is discovered.
The survival of pancreatic cancer without treatment is very poor. With treatment improvements in survival can be achieved for nearly all patients. The extent of this depends on the initial stage of the tumour and the therapy that can be tolerated.
Yes, cancer therapy is constantly advancing and evolving with new drugs and treatments becoming available. Many new treatments are only initially available as part of a clinical trial with others only suitable to a small number of patients. Prof Samra will closely and under the guidance of your Medical Oncologist as to which treatment would be best suitable for you.
Yes, Prof Samra can provide information on any potential clinical trial related to your care, if you are eligible for a clinical trial, Prof Samra will connect you with a Medical Oncologist who can provide further advice and treatment of the trial .
Recovery from Pancreatic cancer is not always possible. If cancer cannot be cured or controlled, the disease may become terminal. Further aggressive treatment during this stage but may not be advantageous and worsen the quality of life.
This situation is stressful, and for many people, advanced cancer is difficult to discuss, especially with family and friends. However, it is important to have open and honest conversations with your health care team and express your feelings, preferences, and concerns. The health care team is there to help, and many team members have special skills, experience, and knowledge to support patients and their families during this time. Making sure a person is physically comfortable and free from pain is extremely important.
People who have advanced cancer and who are expected to live less than 6 months may find the service of a palliative care team to aid patients and their families.
After potentially curative treatment has finished your journey continues with your doctors and specialist nurses. Regular visits to your treating specialists are conducted by your surgeon and oncologist (usually on an alternating basis). Regular blood test and physical examination are carried out, initially at 3 monthly intervals. CT scans are performed less regularly to assess to see if the tumour has recurred.
Waiting for these test results can cause significant anxiety given the serious nature of a positive result. Talk to your treating specialists as there may be ways to help with these feelings. A survivorship programme can help return to normal life after treatment and cope with the effects of the diagnosis, disease and treatment.